Ontruzant

Active Ingredient(s): Trastuzumab-dttb
FDA Approved: * January 18, 2019
Pharm Company: * SAMSUNG BIOEPIS CO LTD
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Ontruzant Overview

Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer.[3][4][5][6] It is specifically used for cancer that is HER2 receptor positive.[3] It may be used by itself or together with other chemotherapy medication.[3] Trastuzumab is given by slow injection into a vein and injection just under the skin.[3]&am...

Read more Ontruzant Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Trastuzumab

Recent Ontruzant Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Trastuzumab-dttb
  • Injection: 100mg, 150mg, 420mg, 420mg/vial, 440mg, 600mg + 10000units
  • Vial: 100mg, 150mg, 160mg, 21mg/ml, 420mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Ontruzant: (2 results)

Sorted by National Drug Code
  • 0006-5033 Ontruzant 150 mg Intravenous Injection, Powder, Lyophilized, for Solution by Merck Sharp & Dohme Corp.
  • 0006-5034 OntruzantOntruzant Intravenous Kit by Merck Sharp & Dohme Corp.

Other drugs which contain Trastuzumab-dttb or a similar ingredient: (12 results)